Tagged: Cancer treatment
9 Jul, 2012
Mekhala Chaubal
Compulsory licensing, generic medicines, Global Trade and IP, India, IPR enforcement, Patents, TRIPs
In March 2012, the Indian Patent Office made waves in the seas of international patent law, by slashing the domestic prices of the cancer-treatment drug Nexavar, and by issuing the country’s first ever compulsory …
Voted Best IP Blog
